Attenuation of Oxygen‐Induced Neovascularization and Inflammation by Neutralizing VEGFA and/or ANG ‐2 With an Antibody
Genes to Cells · 2026-05 · 31 (3)
DOI: 10.1111/gtc.70107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 07.04.2026. Verfasst von Hirokazu Oohashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Retinal Biology and Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Oxygen, Inflammation, Antibodies, Bispecific, Retinal Neovascularization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chugai Pharmaceutical.
Abstract (Originalsprache)
Neovascularization is a major cause of blindness in various retinal diseases, and inflammation aggravates the pathological and clinical conditions of these diseases. VEGFA or ANG‐2 neutralizing antibodies have been used to block pathological neovascularization. In this work, the effects of intraocular administration of neutralizing antibodies against VEGFA, ANG‐2, or bispecific to these two factors on pathological findings were examined in the oxygen‐induced retinopathy (OIR) mouse model. At both postnatal day (P)17 and P19, anti‐VEGFA and ‐ANG‐2 administration suppressed neovascularization, and the bispecific antibody attenuated neovascularization more efficiently. However, oxygen‐induced vaso‐obliteration was not modified by these antibodies. Numbers of photoreceptor, amacrine, and bipolar cells were reduced in the OIR retina, and the antibodies reversed these changes. Microglia‐specific gene expression increased in the OIR retina, and administration of the antibodies reduced the IBA1‐positive area in the OIR retina, although these antibodies did not affect Iba1 gene expression. Labeled VEGFA and ANG‐2 were found to be co‐localized with microglia, suggesting that VEGFA and ANG‐2 affect microglia activation directly. Taken together, neutralizing antibody to VEGFA or ANG‐2 attenuated oxygen‐induced neovascularization and inflammation, and the bispecific antibody more efficiently suppressed some features than the single antibody to VEGFA or ANG‐2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Retinal Biology and Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Graduate School of Pharmaceutical Sciences, Josai International University, Chiba, Japan.
- Product Research Dept, Chugai Pharmaceutical Co., Ltd., Togane, Kanagawa, Japan.
- Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Toshiro Iwagawa, Yuta Inokuchi, Sumiko Watanabe
Förderung
- Chugai Pharmaceutical
Zitieren
APA
Oohashi, H., Iwagawa, T., Abe, H., Kawaji, C., Inokuchi, Y., Soeda, T., Saita, K., Aihara, M., & Watanabe, S. (2026). Attenuation of Oxygen‐Induced Neovascularization and Inflammation by Neutralizing VEGFA and/or ANG ‐2 With an Antibody. Genes to Cells, 31(3). https://doi.org/10.1111/gtc.70107
Vancouver
Oohashi H, Iwagawa T, Abe H, Kawaji C, Inokuchi Y, Soeda T, et al. Attenuation of Oxygen‐Induced Neovascularization and Inflammation by Neutralizing VEGFA and/or ANG ‐2 With an Antibody. Genes to Cells. 2026;31(3). doi:10.1111/gtc.70107
BibTeX
@article{Oohashi2026,
author = {Oohashi, Hirokazu and Iwagawa, Toshiro and Abe, Hiroto and Kawaji, Chihiro and Inokuchi, Yuta and Soeda, Tetsuhiro and Saita, Kosuke and Aihara, Makoto and Watanabe, Sumiko},
title = {Attenuation of Oxygen‐Induced Neovascularization and Inflammation by Neutralizing VEGFA and/or ANG ‐2 With an Antibody},
journal = {Genes to Cells},
year = {2026},
volume = {31},
number = {3},
doi = {10.1111/gtc.70107}
}
EUVIMED